Christopher Stevenson Email and Phone Number
Christopher Stevenson work email
- Valid
- Valid
- Valid
Christopher Stevenson personal email
Christopher Stevenson phone numbers
Christopher Stevenson is a Chief Scientific Officer, Engitix at Engitix Therapeutics. He possess expertise in asthma, copd, western blotting, drug development, in vitro and 12 more skills.
-
Chief Scientific OfficerEngitix Therapeutics Sep 2023 - PresentLondon, England, Gb
-
Vice President, Global Head Pharmaceutical Sciences, Interventional Oncology At Johnson & JohnsonJohnson & Johnson Sep 2018 - Sep 2023New Brunswick, Nj, Us -
Venture Leader, Copd & Lung Cancer, Disease Interception AcceleratorThe Janssen Pharmaceutical Companies Of Johnson & Johnson Jan 2016 - Sep 2018Raritan, New Jersey, UsLed a DIA venture focused on developing technologies to enable early detection and treatment of individuals at risk for developing COPD or lung cancer to prevent/intercept disease processes.Disease Interception (DI) is a Janssen strategy intended to create a paradigm shift from disease care to health care by initiating an evolution from the diagnosis and treatment of disease to prediction and preemption. The DIA is focused on exploring disease areas most ready for DI strategies, like COPD & lung cancer, and creating solutions that intervene earlier and inhibit progression to disease. Through scientific partnerships, coupled with strong leadership, we hope to transform the way individuals, physicians and health care systems approach health and well-being in the future. -
Head Of Respiratory Discovery, Senior Scientific DirectorThe Janssen Pharmaceutical Companies Of Johnson & Johnson Jul 2015 - Jan 2016Raritan, New Jersey, UsLed the Respivert & Janssen pulmonary discovery strategy and portfolio. Discovery representative on all Respivert clinical development teams and was responsible for biomarker strategies in early clinical studies.
-
Honorary Professor In Chronic Obstructive Pulmonary DiseaseUniversity Of Southern Denmark Feb 2012 - Jan 2017Odense, Dk -
Head Of Biology, Senior Scientific DirectorRespivert, Ltd. Mar 2014 - Jan 2016 -
Honorary Lecturer, Respiratory PharmacologyImperial College London Jan 2010 - May 2014London, GbPreclinical respiratory in vivo pharmacology and translational biology. Respiratory Pharmacology Group, Pharmacology and Toxicology Section, Centre of Integrative Mammalian Physiology and Pharmacology, Centre of Respiratory Infections, National Heart and Lung Institute, Imperial College London. -
Lecturer, Respiratory PharmacologyImperial College London Jul 2007 - Jan 2010London, GbPreclinical respiratory in vivo pharmacology and translational biology. Respiratory Pharmacology Group, Pharmacology and Toxicology Section, Centre of Integrative Mammalian Physiology and Pharmacology, Centre of Respiratory Infections, National Heart and Lung Institute, Imperial College London.
-
Translational Biology Unit HeadNovartis Institutes For Biomedical Research Dec 2012 - Mar 2014Basel, Baselstadt, ChLead a multi-disciplinary team of immunologists, pharmacologists, and bioinformaticians Phase 0 clinical studies aiming to define sub-phenotypes of chronic respiratory diseases by integrating clinical phenotyping data with genomic & molecular profiling data.Define translational utility of preclinical (in vivo and in vitro) systems using integrative analysis of molecular, metabolite, and pathophysiological data from preclinical models and clinical studiesDevelop human lung tissue and primary cell models using material from subjects with chronic respiratory diseases to validate target mechanisms identified through molecular phenotyping of carefully defined patient populationsProject leader of preclinical drug discovery projects, including biologics and inhalation molecules aimed at treating acute & chronic respiratory conditions. -
Research Leader, Respiratory Pharmacology & Translational BiologyRoche Jan 2010 - Dec 2012Switzerland 🇨🇭 , ChPreclinical respiratory in vivo & in vitro pharmacologyAsthma, COPD and IPF translational biologyInflammation BiologyInflammation Disease Therapeutic AreaDrug discoveryInhalation pharmacology & drug development -
Research Investigator, Respiratory PharmacologyNovartis Institutes For Biomedical Research May 2002 - Jul 2007Basel, Baselstadt, ChPreclinical respiratory in vivo pharmacology and translational biology. COPD and airway pharmacology researchRespiratory In Vivo Pharmacology UnitRespiratory Disease Area
Christopher Stevenson Skills
Christopher Stevenson Education Details
-
Uc Santa BarbaraPharmacology
Frequently Asked Questions about Christopher Stevenson
What company does Christopher Stevenson work for?
Christopher Stevenson works for Engitix Therapeutics
What is Christopher Stevenson's role at the current company?
Christopher Stevenson's current role is Chief Scientific Officer, Engitix.
What is Christopher Stevenson's email address?
Christopher Stevenson's email address is ch****@****che.com
What is Christopher Stevenson's direct phone number?
Christopher Stevenson's direct phone number is +197323*****
What schools did Christopher Stevenson attend?
Christopher Stevenson attended Uc Santa Barbara.
What skills is Christopher Stevenson known for?
Christopher Stevenson has skills like Asthma, Copd, Western Blotting, Drug Development, In Vitro, In Vivo, Translational Research, Physiology, Inflammation, Clinical Development, Animal Models, Translational Medicine.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial